Aclaris Therapeutics, Inc. (ACRS) — Biotechnology. Numbers-first dossier: valuation, distress risk, calibrated signal.

How we compute this

ACRSpeers & supply-chain relationships

ACRS earnings history

Qtick
Sign in
Bid — × — AskUpdated Sep 25, 2026 · 4:00 PM ETVol 1.47M · 3-mo avg 2.15M

Aclaris Therapeutics, Inc. (ACRS)

ACRSAclaris Therapeutics, Inc.loading…
loading…
QTick signal
-2net
1 bull / 1 bear factors · balanced
Bull 2 pts·Bear 4 pts30d
loading…
Market context—Sector read · not on fileRiskBalance sheet · Distress—PCE inflation days · not on fileOKNeutral tape · 25/100 · as of 2026-09-25
Smart entry
$5.12
basis · pivot low + s1 · as of 2026-09-25
Target exit zone
$5.76
center $5.76 · basis · sma 50 + vwap 50 · as of 2026-09-25
Implied move · 1 wk
—
not on file
Chart pattern
Golden cross
50d above 200d · but price is 11% below the 50-day — structure damaged
Pullback risk
In line
1.21× the norm · 96% saw a ≥10% dip · 63d · tape state: neutral · capped: at bottom zone (4/6 bottoming checks met)
Chart pattern
Golden cross
50d above 200d · but price is 11% below the 50-day — structure damaged
Volume vs its own 20-session average0.56×
52-week range$1.74 – $6.60
Below high since 2015-85.4% · $35.30 high
Risk / reward0.80 : 1
Plan stop$4.39
Max pain—
RSI 1439.3 fires under 35 · fires near $4.84
Forensic flags1 review
Earnings multiplen.m. — no profit expected
P/E vs its own pastnot on file
Price / booknot on file

Last session traded lighter than its own normal, price down 4.3%. Over the last 20 sessions, 51% of the volume traded on days the stock closed lower.

Entry strategy · 10 triggers

3 of 5 aligned — not yet
RSI 14
●
39.3
fires under 35 · fires near $4.84
vs 50-day
✓
$5.77
below the line
Bollinger
●
$5.02
no lower pierce · fires near $4.98
VWAP 20
✓
$5.59
below the rolling VWAP
Entry level
✓
$5.12
within 1% of model level
Put wall
●
—
not on file
MACD
Context●
-0.05
below zero · still falling
RVolStatic
0.56×
lighter than its own normal
Short int.Static
14.2%
short interest below 20%
ATRStatic
$0.37
14-session average true range
A checklist, not odds on a return: 3 of 5 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
See the full case→
Next earnings
2026-11-05
in 29 sessions
Next dividend
No indicated yield
no forward dividend on file
Aclaris Therapeutics, Inc. (ACRS) Stock Price & Signals · QTick